×
Back to Agenda
ON DEMAND - Setting a Strategic Foundation for Mutually Beneficial Collaborations Between Industry and Patient Organizations
Session Chair(s)
Ellen Coleman, MPH, MS
President and Chief Executive Officer, VOZ Advisors, United States
This forum will share recommendations and present examples for how companies can strategically and compliantly identify and engage priority patient organizations and patients to collaborate on shared goals across the drug development continuum.
Learning Objective : Discuss best practices for evaluating and identifying priority organizations; Identify appropriate timing for conducting environmental assessments and how their insights can be used to enhance knowledge for cross-functional teams; Define the lifecycle of a patient organization, common challenges they experience and how industry can help organizations build capacity
Speaker(s)
How the Right Relationships Support Business Objectives
Head of Global Patient Affairs, Blueprint Medicine, United States
Why All Patient Stories Are Not Equal?
Executive Director, The Myositis Association, United States
A Comprehensive Approach to Patient Centricity: Case Study and Data Review of a Joint Pharma, Advocacy, and Partner Effort
Sr. Director of Nursing Solutions, Science 37, United States
Industry Update
Senior Clinical Trial Manager, Kezar Life Sciences, United States
Have an account?